🇺🇸 FDA
Pipeline program

MIDOSTAURIN, ARACYTIN 500 mg/10 ml Polvere e Solvente per Soluzione Iniettabile, DAUNORUBICIN HYDROCHLORIDE

GIMEMA AML1919

Phase 3 small_molecule active

Quick answer

MIDOSTAURIN, ARACYTIN 500 mg/10 ml Polvere e Solvente per Soluzione Iniettabile, DAUNORUBICIN HYDROCHLORIDE for Acute Myeloid Leukemia (LMA) with FLT3 mutation is a Phase 3 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
Acute Myeloid Leukemia (LMA) with FLT3 mutation
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials